Distinct mechanisms of innate and adaptive immune regulation underlie poor oncologic outcomes associated with KRAS-TP53 co-alteration in pancreatic cancer

Jashodeep Datta, Anna Bianchi, Iago De Castro Silva, Nilesh Deshpande, Long Cao, Siddharth Mehra, Samara P. Singh, Christine I. Rafie, Xiaodian Sun, Xi Chen, Xizi Dai, Antonio Colaprico, Prateek Sharma, Austin R. Dosch, Asha Pillai, Peter J. Hosein, Nagaraj S. Nagathihalli, Krishna V. Komanduri, Julie M. Wilson, Yuguang Ban, Nipun B. Merchant